Atrium Therapeutics, Inc. insider trading

RNANASDAQ

$7.84-0.30 (-3.69%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Feb 27, 2026 to Oct 2, 2026. Price (-46.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Unlock quarterly net flow

Key players

SBSarah BoyceDirector0.8107%of company
KPKathleen P. GallagherSee Remarks0.6999%of company
SGSteven George HughesChief Medical Officer0.3019%of company
HYHusam YounisChief Scientific Officer0.2423%of company
RMRocio Martin HoyosChief Strategy Officer0.2241%of company
BRBrendan R. WinslowChief Financial Officer0.2155%of company
SKStephanie KenneySee Remarks0.1934%of company
FWFlanagan W. MichaelDirector0.1869%of company
TETroy Edward WilsonDirector0.0686%of company
CBCarsten BoessDirector0.0643%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
No qualifying insider activity was found for the selected filters.

End of history · 0 transactions